Thalidomide impairs insulin action on glucose uptake and glycogen synthesis in patients with type 2 diabetes

Diabetes Care

Volumn 23, Issue 8, 2000, Pages 1172-1176

  Iqbal, Nayyar ^a   Zayed, Mahmoud ^a   Boden, Guenther ^a  

^a TEMPLE UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; FATTY ACID; GLUCOSE; LACTIC ACID; THALIDOMIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; ESTERIFICATION; FATTY ACID METABOLISM; FEMALE; GLUCONEOGENESIS; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; GLYCOGEN SYNTHESIS; GLYCOLYSIS; HUMAN; INSULIN RESISTANCE; LIPOLYSIS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATION; SINGLE BLIND PROCEDURE;

EID: 0033859992     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.23.8.1172     Document Type: Article

References (23)

1. Antitumor activity of thalidomide in refractory multiple myeloma
2. Thalidomide treatment reduces TNF-α production and enhances weight gain in patients with pulmonary tuberculosis
3. Immunomodulatory assays to study structure-activity relationships of thalidomide
4. Tumor necrosis factor-α: A key component of the obesity-diabetes link
5. Tumor necrosis factor-alpha suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates
6. Tumor necrosis factor-alpha inhibits signaling from the insulin receptor
7. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes: Central role of tumor necrosis factor-alpha
8. Gene expression of GLUT4 in skeletal muscle from insulin-resistant patients with obesity, IGT, GDM, and NIDDM
9. Transcriptional repression of the GLUT4 and C/EBP genes in 3T3-L1 adipocytes by tumor necrosis factor-alpha
10. In vivo and in vitro effects of antiinsulin receptor antibodies
11. Use of a variable tracer infusion method to determine glucose turnover in humans
12. Measurement of size and turnover rate of body glucose pool by the isotope dilution method
13. Quantitation of glycolysis and skeletal muscle glycogen synthesis in humans
14. Release, oxidation and reesterification of fatty acids from infused triglycerides: Effect of heparin
15. Effects of therapy on the nature and quantity of fuels oxidized during diabetic ketoacidosis
16. Effect of hyperinsulinemia on urea pool size and substrate oxidation rates
17. Total body water in pregnancy: Assessment by using bioelectrical impedance
18. Mechanisms of fatty acid-induced inhibition of glucose uptake
19. Randomized comparison of thalidomide versus placebo in toxic epidermal necrolysis
20. Thalidomide promotes the release of tumor necrosis factor-α (TNF-α) and lethality by lipopolysaccharide in mice
21. Dose-dependent effect of insulin on plasma free fatty acid turnover and oxidation in humans
22. The effect of thalidomide on the pathogenesis of human immunodeficiency virus type 1 and M. tuberculosis infection
23. The metabolic and immunologic effects of short-term thalidomide treatment of patients infected with the human immunodeficiency virus